Tanaji T. Talele
Journal of Medicinal Chemistry · 1999–2016
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Tanaji T. Talele trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Tanaji T. Talele overall
Papers from Tanaji T. Talele's perspective
Ordered by how strongly the researchers Tanaji T. Talele trusts endorse each paper. Same corpus, a different order for every researcher.
- HSP90 and the chaperoning of cancer (Nature Reviews. Cancer)
- Targeting proteases: successes, failures and future prospects (Nature reviews. Drug discovery)
- Structure and mechanism of the Hsp90 molecular chaperone machinery. (Annual Review of Biochemistry)
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
- An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus (Nature)
- Neuraminidase inhibitors for influenza. (New England Journal of Medicine)
- A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.
- Polo-like kinases and the orchestration of cell division (Nature reviews. Molecular cell biology)
- Adapting Proteostasis for Disease Intervention (Science)
- The Protein Data Bank.
Their papers
- Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. (2010) — 344 citations
- The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. (2016) — 703 citations
- Three-dimensional quantitative structure-activity relationship (QSAR) and receptor mapping of cytochrome P-450(14 alpha DM) inhibiting azole antifungal agents. (1999)
- Three‐Dimensional Quantitative Structure—Activity Relationship (QSAR) and Receptor Mapping of Cytochrome P‐45014αDM Inhibiting Azole Antifungal Agents. (1999)